First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study
Authors:
- Ali Rıza AkyüzAAAli Rıza Akyüz
- Ali Hakan KonuşAKAli Hakan Konuş
- Ömer Faruk ÇırakoğluÖÇÖmer Faruk Çırakoğlu
- Sinan ŞahinSŞSinan Şahin
- Selim KulSKSelim Kul
- Levent KorkmazLKLevent Korkmaz
- 13 October 2021
- journal article
- research article
- Published by Springer Nature in Herz
- Vol. 47 (5) , 449-455
Abstract
Background In the present article, we present our first experiences with a new type of balloon-expandable Myval valve (Meril Life Sciences, Gujarat, India). Materials and methods A total of 25 consecutive patients who underwent transcatheter aortic valve implantation (TAVI) from June 2020 to November 2020 were included in the study. Results The mean age of the study population was 83 (75–87) years; 17 (68%) were female, and 20 (80%) had hypertension. The Society of Thoracic Surgeons (STS) score of the group was 5.4% ± 3.5%. TAVI was performed via the transfemoral route on all patients. In 19 (76%) cases, we started the procedure without predilation. In two (10.5%) cases performed without predilation, the prosthesis did not pass the native valve. We had to implant the valve from the descending aorta in one (4%) patient. We used Prostar XL (Abbott Vascular, Santa Clara, CA, USA) for six (24%) patients and ProGlide (Abbott Vascular) for 19 (76%) patients for vascular closure. Two (8%) in-hospital deaths occurred in our study but there were no deaths in the 30-day and 90-day follow-up. Vascular complications were observed in one (4%) patient. None of the patients in our study had severe paravalvular leak (PVL), while two (8%) patients had moderate PVL. A permanent pacemaker (PPM) was required in two (8%) patients for the indication of complete atrioventricular block. The mean hospital stay for the whole group was 4 (3–7) days. Conclusion Based on our experiences, the new balloon-expandable valve Myval is easy to use, efficient, and has only a few negligible drawbacks such as the need for predilation of the sheath. While shaft flexibility may have advantages in some situations including in very tortuous arteries, it may cause some difficulties in alignment of the valves.Keywords
This publication has 17 references indexed in Scilit:
- Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk PatientsNew England Journal of Medicine, 2019
- Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2019
- Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to OutcomesJACC, 2017
- Comparison of EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in Cardiac Surgery PatientsThe Annals of Thoracic Surgery, 2016
- Paravalvular Regurgitation After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2016
- Comparison between the SAPIEN S3 and the SAPIEN XT transcatheter heart valves: A single-center experienceWorld Journal of Cardiology, 2016
- 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trialThe Lancet, 2015
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document†European Heart Journal, 2012
- Clinical Outcomes After Transcatheter Aortic Valve Replacement Using Valve Academic Research Consortium DefinitionsJACC, 2012
- Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic StenosisCirculation, 2002